Concepedia

Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing

Joseph A. DiMasi, Zachary Smith, Kenneth Getz

Clinical Therapeutics · 2018 · 14 citations · 4 references

DOI

Concepts

References

4

Innovation in the pharmaceutical industry: New estimates of R&D costs

Joseph A. DiMasi, Henry G. Grabowski, Ronald W. Hansen · Journal of Health Economics · 2016 · 3.2K citations

, , +15

The Value of Improving the Productivity of the Drug Development Process

Joseph A. DiMasi · PharmacoEconomics · 2002 · 231 citations

, , +10

Cost-effectiveness analysis and innovation

Anupam B. Jena, Tomas Philipson · Journal of Health Economics · 2008 · 105 citations

, , +11

Decline In Economic Returns From New Drugs Raises Questions About Sustaining Innovations

Ernst R. Berndt, Deanna Nass, Michael Kleinrock et al. · Health Affairs · 2015 · 68 citations

, , +9